Crescendo Biologics to Present at Biotech Showcase™ 2015

CAMBRIDGE, England, January 6, 2015 /PRNewswire/ --

Crescendo Biologics, a company focused on the discovery and development of best-in-class Humabody™ human V_H antibody fragment therapeutics, today announces its CEO Dr Mike Romanos will be presenting at the Biotech Showcase™ 2015 Conference being held in San Francisco, CA.

Details of Crescendo's presentation are as follows:

Date:        Monday 12^th January 2015    
Time:        11:00 am    
Track:       A - Hearst (4th Floor)
Location:    Parc 55 Wyndham San Francisco - Union Square Hotel

Co-produced by Demy-Colton Life Science Advisors and EBD Group, Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences.

About Crescendo Biologics Ltd 

Crescendo Biologics, based in Cambridge, UK, is focused on the discovery and development of best-in-class Humabody™ human V_H antibody fragment therapeutics, using its novel transgenic platform. Crescendo is enabling the major V_H product formats (multivalent, half-life-extended and topical) for its own pipeline, focused in inflammation and oncology, and to make it the partner of choice for human V_H fragment therapeutics.

http://www.crescendobiologics.com

Contacts
Mike Romanos
Crescendo Biologics
Tel: +44(0)1223-497140
Email: mromanos@crescendobiologics.com

Chris Gardner
Citigate Dewe Rogerson
Tel: +44(0)207-638-9571
Email: chris.gardner@citigatedr.co.uk